{"id":1012,"date":"2026-05-25T03:50:16","date_gmt":"2026-05-25T03:50:16","guid":{"rendered":"https:\/\/wuhantopmiraclepeptides.com\/?post_type=product&p=1012"},"modified":"2026-06-04T06:40:12","modified_gmt":"2026-06-04T06:40:12","slug":"lc216-multi-peptide","status":"publish","type":"product","link":"https:\/\/wuhantopmiraclepeptides.com\/index.php\/product\/lc216-multi-peptide\/","title":{"rendered":"LC216 Multi-Peptide"},"content":{"rendered":"

LC216 Multi-Peptide: Essential for Advanced Metabolic & Lipid Research<\/span><\/h1>\n

In the evolving field of metabolic research, one formulation has gained significant attention:\u00a0<\/span>LC216 multi-peptide<\/span><\/strong>. This carefully structured lipotropic compound combines essential amino acids, B-vitamins, and methylation cofactors to create a comprehensive research tool for studying fat metabolism, hepatic lipid processing, mitochondrial energy transfer, and cellular methylation pathways. At Wuhan Top Miracle Peptides, we supply high-purity\u00a0<\/span>LC216 multi-peptide<\/span><\/strong>\u00a0to research institutions, laboratories, and wholesale buyers across the United Kingdom, France, Germany, Spain, Sweden, Italy, and the USA. Every batch is lab-tested and backed by Certificates of Analysis (COA), ensuring your research is built on a foundation of quality, reproducibility, and scientific integrity.<\/span><\/p>\n

What Is LC216 Multi-Peptide?<\/span><\/h2>\n

At its core,\u00a0<\/span>LC216 multi-peptide<\/span><\/strong>\u00a0is a research-grade, multi-component liquid formulation designed specifically for in vitro laboratory studies. Unlike single-compound peptides, LC216 is a synergistic blend of eight active ingredients that work together to model complex metabolic interactions. The “216” designation refers to the\u00a0<\/span>216mg total concentration of active compounds<\/span><\/strong>, carefully formulated to support controlled experimentation into lipotropic behavior, methylation cycles, and cofactor pathways.<\/span><\/p>\n

The Synergistic Composition of LC216<\/span><\/h3>\n

Each 10mL vial of\u00a0<\/span>LC216 multi-peptide<\/span><\/strong>\u00a0contains a precise combination of eight research compounds:<\/span><\/p>\n

\n
\n
<\/div>\n
<\/div>\n<\/div>\n\n\n\n\n\n\n\n\n\n\n\n\n
Component<\/span><\/th>\nConcentration per mL<\/span><\/th>\nPrimary Research Focus<\/span><\/th>\n<\/tr>\n<\/thead>\n
Inositol<\/span><\/td>\n50mg<\/span><\/td>\nInsulin signaling & membrane function<\/span><\/td>\n<\/tr>\n
Choline<\/span><\/td>\n50mg<\/span><\/td>\nVLDL synthesis & fat export<\/span><\/td>\n<\/tr>\n
Methionine<\/span><\/td>\n25mg<\/span><\/td>\nMethylation & epigenetic regulation<\/span><\/td>\n<\/tr>\n
L-Carnitine<\/span><\/td>\n20mg<\/span><\/td>\nFatty acid transport & mitochondrial shuttling<\/span><\/td>\n<\/tr>\n
L-Arginine<\/span><\/td>\n20mg<\/span><\/td>\nNitric oxide pathway signaling<\/span><\/td>\n<\/tr>\n
Vitamin B6 (Pyridoxine)<\/span><\/td>\n25mg<\/span><\/td>\nEnzymatic cofactor research<\/span><\/td>\n<\/tr>\n
Vitamin B1 (Thiamine)<\/span><\/td>\n25mg<\/span><\/td>\nCarbohydrate metabolism modeling<\/span><\/td>\n<\/tr>\n
Vitamin B12 (Methylcobalamin)<\/span><\/td>\n1mg<\/span><\/td>\nMethylation & cellular cofactor studies<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n

Research Note:<\/span><\/strong>\u00a0Some formulations may also include Vitamin B5 (Dexpanthenol) at 25mg per mL as an additional cofactor for enzymatic research applications<\/span>.<\/span><\/p>\n

The “MIC” Core: Understanding the Primary Mechanism<\/span><\/h3>\n

The scientific interest in\u00a0<\/span>LC216 multi-peptide<\/span><\/strong>\u00a0centers on its “MIC” core\u2014Methionine, Inositol, and Choline. These three lipotropic agents are the primary drivers of the formulation’s utility in metabolic pathway research.<\/span><\/p>\n

Methionine<\/span><\/strong>\u00a0acts as a critical methyl donor. In research models, Methionine influences DNA methylation and the epigenetic regulation of metabolic genes. It serves as the precursor to SAMe (S-adenosylmethionine), which plays a fundamental role in preventing lipid accumulation and supporting normal cellular methylation cycles.<\/span><\/p>\n

Choline<\/span><\/strong>\u00a0provides structural support. It is required to synthesize phosphatidylcholine, the primary phospholipid used to build VLDL (Very Low-Density Lipoprotein) particles. Without VLDL, the liver cannot effectively package triglycerides for export. LC216-based research often measures VLDL secretion rates to understand systemic lipid dynamics.<\/span><\/p>\n

Inositol<\/span><\/strong>\u00a0functions as a secondary messenger in cell membrane signaling and helps regulate insulin sensitivity. By combining these three lipotropic agents, LC216 allows researchers to study the complete “mobilization” phase of metabolism\u2014moving stored fats out of hepatic storage and into circulation for potential oxidation.<\/span><\/p>\n

Key Research Applications for LC216 Multi-Peptide<\/span><\/h2>\n

Laboratory research has explored\u00a0<\/span>LC216 multi-peptide<\/span><\/strong>\u00a0across several distinct domains. Each application leverages the formulation’s unique composition to address specific experimental questions.<\/span><\/p>\n

Hepatic Lipid Metabolism & Steatosis Research<\/span><\/h3>\n

The most prominent area of study involves understanding how lipotropic agents influence fat accumulation in the liver. In methionine-choline deficient diet models (a standard method for inducing fatty liver in rats), researchers have observed that the reintroduction of Methionine and Choline helps restore normal lipid transport<\/span>. LC216 provides a complete model system for studying:<\/span><\/p>\n